Lin C, Yu C, Shen C, Liu C, Chao T, Huang C
Med Oncol. 2022; 39(12):242.
PMID: 36180600
DOI: 10.1007/s12032-022-01812-x.
Cullen M, Lemeshow A, Russo L, Barnes D, Ababio Y, Habtezion A
Healthcare (Basel). 2022; 10(4).
PMID: 35455781
PMC: 9025451.
DOI: 10.3390/healthcare10040603.
Lyons M, Fernandez Poole S, Brownson R, Lyn R
Int J Environ Res Public Health. 2022; 19(2).
PMID: 35055453
PMC: 8775540.
DOI: 10.3390/ijerph19020632.
Vijayasiri G, Molina Y, Chukwudozie I, Tejeda S, Pauls H, Rauscher G
J Health Dispar Res Pract. 2021; 11(3).
PMID: 34026339
PMC: 8136761.
Nathanson S, Detmar M, Padera T, Yates L, Welch D, Beadnell T
Clin Exp Metastasis. 2021; 39(1):117-137.
PMID: 33950409
PMC: 8568733.
DOI: 10.1007/s10585-021-10090-2.
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion.
Yao S, Cheng T, Elkhanany A, Yan L, Omilian A, Abrams S
J Natl Cancer Inst. 2021; 113(8):1036-1043.
PMID: 33395700
PMC: 8328978.
DOI: 10.1093/jnci/djaa215.
Genetic factors associated with cancer racial disparity - an integrative study across twenty-one cancer types.
Li Y, Pang X, Cui Z, Zhou Y, Mao F, Lin Y
Mol Oncol. 2020; 14(11):2775-2786.
PMID: 32920960
PMC: 7607166.
DOI: 10.1002/1878-0261.12799.
Editor's Choice: Deliberative and non-deliberative effects of descriptive and injunctive norms on cancer screening behaviors among African Americans.
Manning M, Lucas T, Davis S, Valdimarsdottir H, Thompson H
Psychol Health. 2019; 35(7):774-794.
PMID: 31747816
PMC: 7237304.
DOI: 10.1080/08870446.2019.1691725.
Neighborhood Social Determinants of Triple Negative Breast Cancer.
Hossain F, Danos D, Prakash O, Gilliland A, Ferguson T, Simonsen N
Front Public Health. 2019; 7:18.
PMID: 30834239
PMC: 6387917.
DOI: 10.3389/fpubh.2019.00018.
Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies.
Guerrero S, Lopez-Cortes A, Indacochea A, Garcia-Cardenas J, Zambrano A, Cabrera-Andrade A
Sci Rep. 2018; 8(1):13978.
PMID: 30228363
PMC: 6143551.
DOI: 10.1038/s41598-018-32264-x.
Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
Adams A, Madden J, Zhang F, Lu C, Ross-Degnan D, Lee A
Value Health. 2017; 20(10):1345-1354.
PMID: 29241894
PMC: 5734096.
DOI: 10.1016/j.jval.2017.05.023.
Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer.
Telonis A, Rigoutsos I
Cancer Res. 2017; 78(5):1140-1154.
PMID: 29229607
PMC: 5935570.
DOI: 10.1158/0008-5472.CAN-17-1947.
Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
Roseland M, Schwartz K, Ruterbusch J, Lamerato L, Krajenta R, Booza J
Breast Cancer Res Treat. 2017; 165(1):163-168.
PMID: 28547656
PMC: 6849388.
DOI: 10.1007/s10549-017-4300-y.
Inadequate Cancer Screening: Lack of Provider Continuity is a Greater Obstacle than Medical Mistrust.
Arnold L, McGilvray M, Kyle Cooper J, James A
J Health Care Poor Underserved. 2017; 28(1):362-377.
PMID: 28239007
PMC: 5483852.
DOI: 10.1353/hpu.2017.0028.
Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse Populations.
Seijo E, Lima D, Iriabho E, Almeida J, Monico J, Echeverri M
Cancer Control. 2016; 23(4):383-389.
PMID: 27842327
PMC: 5268085.
DOI: 10.1177/107327481602300409.
Sleep duration and breast cancer risk among black and white women.
Xiao Q, Signorello L, Brinton L, Cohen S, Blot W, Matthews C
Sleep Med. 2016; 20:25-9.
PMID: 27318222
PMC: 4913026.
DOI: 10.1016/j.sleep.2015.11.010.
Breast Cancer Risk Factors among Ugandan Women at a Tertiary Hospital: A Case-Control Study.
Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A
Oncology. 2016; 90(6):356-62.
PMID: 27104645
PMC: 4948678.
DOI: 10.1159/000445379.
Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.
Swede H, Sarwar A, Magge A, Braithwaite D, Cook L, Gregorio D
Cancer Causes Control. 2016; 27(5):627-36.
PMID: 27000206
PMC: 5591028.
DOI: 10.1007/s10552-016-0736-3.
Medical advocacy among African-American women diagnosed with breast cancer: from recipient to resource.
Molina Y, Scherman A, Constant T, Hempstead B, Thompson-Dodd J, Richardson S
Support Care Cancer. 2016; 24(7):3077-84.
PMID: 26891843
PMC: 4879045.
DOI: 10.1007/s00520-016-3123-4.
Integration of molecular pathology, epidemiology and social science for global precision medicine.
Nishi A, Milner Jr D, Giovannucci E, Nishihara R, Tan A, Kawachi I
Expert Rev Mol Diagn. 2015; 16(1):11-23.
PMID: 26636627
PMC: 4713314.
DOI: 10.1586/14737159.2016.1115346.